Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
出版年份 2021 全文链接
标题
Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
作者
关键词
-
出版物
Infectious Diseases and Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-10
DOI
10.1007/s40121-021-00516-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
- (2021) Sajad Yaghoubi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
- (2020) Lei Zha et al. ADVANCES IN THERAPY
- Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants
- (2020) Victoria Allan et al. Journal of Comparative Effectiveness Research
- Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
- (2020) Gennaro De Pascale et al. Annals of Intensive Care
- Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia
- (2019) Megan D Shah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other among Patients with Serious Infections due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
- (2019) Thomas Lodise et al. Open Forum Infectious Diseases
- Activity of potential alternative treatment agents for Stenotrophomonas maltophilia non-susceptible to levofloxacin and/or trimethoprim/sulfamethoxazole
- (2019) M Biagi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome
- (2019) Wafa Ibn Saied et al. JOURNAL OF INFECTION
- Growing resistance in Stenotrophomonas maltophilia?
- (2019) Hannah H Matson et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
- (2018) L. Papst et al. CLINICAL MICROBIOLOGY AND INFECTION
- Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
- (2018) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
- (2018) Peter M Hawkey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Frequency and Genetic Determinants of Tigecycline Resistance in Clinically Isolated Stenotrophomonas maltophilia in Beijing, China
- (2018) Jin Zhao et al. Frontiers in Microbiology
- Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
- (2018) J.-H. Ko et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis
- (2017) Philipp P. Kohler et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005–2014
- (2017) Li-Fen Hu et al. JOURNAL OF CHEMOTHERAPY
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy
- (2017) Anthony A. Adegoke et al. Frontiers in Microbiology
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections
- (2016) Elizabeth Hand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Duration of antibiotic therapy in the intensive care unit
- (2016) Gabor Zilahi et al. Journal of Thoracic Disease
- Ventilator-Associated Events
- (2015) Lila Bouadma et al. CRITICAL CARE MEDICINE
- Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
- (2015) Fengcai Shen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Review of Tigecycline
- (2014) G.L. French JOURNAL OF CHEMOTHERAPY
- Validation of the Charlson Comorbidity Index in Acutely Hospitalized Elderly Adults: A Prospective Cohort Study
- (2014) Wijnanda J. Frenkel et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Developing a New, National Approach to Surveillance for Ventilator-Associated Events
- (2013) S. S. Magill et al. AMERICAN JOURNAL OF CRITICAL CARE
- Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)
- (2013) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections
- (2013) Paschalina Kontou et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Power failure: why small sample size undermines the reliability of neuroscience
- (2013) Katherine S. Button et al. NATURE REVIEWS NEUROSCIENCE
- High content live cell imaging for the discovery of new antimalarial marine natural products
- (2012) Serena Cervantes et al. BMC INFECTIOUS DISEASES
- What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
- (2012) D. F. Florescu et al. CLINICAL INFECTIOUS DISEASES
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
- (2012) P. Prasad et al. CLINICAL INFECTIOUS DISEASES
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
- (2012) Po-Liang Lu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections
- (2012) Yasemin Tezer Tekçe et al. JOURNAL OF CHEMOTHERAPY
- Attributable Mortality of Ventilator-Associated Pneumonia
- (2011) Maarten Bekaert et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetic and pharmacodynamic evaluation of tigecycline
- (2011) Helen Giamarellou et al. Expert Opinion on Drug Metabolism & Toxicology
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Susceptibilities of a Worldwide Collection of Stenotrophomonas maltophilia Isolates Tested against Tigecycline and Agents Commonly Used for S. maltophilia Infections
- (2010) D. J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Stenotrophomonas maltophilia: an emerging opportunist human pathogen
- (2009) W John Looney et al. LANCET INFECTIOUS DISEASES
- Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria
- (2008) Katherine E. Kollef et al. CHEST
- Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia
- (2008) J. I. Garcia Paez et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review
- (2008) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started